ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TRVN Trevena Inc

0.3549
-0.0111 (-3.03%)
After Hours
Last Updated: 18:14:26
Delayed by 15 minutes

Period:

Draw Mode:

Volume 170,248
Bid Price 0.3501
Ask Price 0.3548
News -
Day High 0.3599

Low
0.3227

52 Week Range

High
3.28

Day Low 0.3227
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0111 -3.03% 0.3549 18:14:26
Open Price Low Price High Price Close Price Prev Close
0.347 0.3227 0.3599 0.352 0.366
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
426 170,248 $ 0.3451503 $ 58,761 - 0.3227 - 3.28
Last Trade Time Type Quantity Stock Price Currency
17:15:36 formt 134 $ 0.3549 USD

Trevena Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.41M 18.32M - 3.13M -40.29M -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRVN Message Board. Create One! See More Posts on TRVN Message Board See More Message Board Posts

Historical TRVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4190.430.32270.39230481,017,174-0.0641-15.30%
1 Month0.5090.510.32270.399087382,916-0.1541-30.28%
3 Months0.63830.700.32270.4693645206,579-0.2834-44.40%
6 Months0.60950.76930.32270.5356381160,994-0.2546-41.77%
1 Year0.73013.280.32271.96999,247-0.3752-51.39%
3 Years45.37555.000.322717.661,165,930-45.02-99.22%
5 Years37.00112.500.322740.131,940,454-36.65-99.04%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Your Recent History

Delayed Upgrade Clock